These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15882534)

  • 41. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
    Souayah N; Nasar A; Suri MF; Qureshi AI
    Vaccine; 2007 Jul; 25(29):5253-5. PubMed ID: 17560693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza vaccine effectiveness and confounding factors among young children.
    Fujieda M; Maeda A; Kondo K; Fukushima W; Ohfuji S; Kaji M; Hirota Y
    Vaccine; 2008 Nov; 26(50):6481-5. PubMed ID: 18573294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
    Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
    Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of an influenza vaccination campaign in rural environment].
    Gavira Iglesias FJ; Rodríguez López FC; Berni Maestre RM
    Rev Sanid Hig Publica (Madr); 1987; 61(7-8):759-81. PubMed ID: 3438696
    [No Abstract]   [Full Text] [Related]  

  • 46. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children.
    Schanzer DL; Langley JM; Tam TW
    Pediatr Infect Dis J; 2006 Sep; 25(9):795-800. PubMed ID: 16940836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
    Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
    Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated inflammatory mediators in adults with oculorespiratory syndrome following influenza immunization: a public health agency of Canada/Canadian Institutes of Health Research Influenza Research Network Study.
    Al-Dabbagh M; Lapphra K; Scheifele DW; Halperin SA; Langley JM; Cho P; Kollmann TR; Li Y; De Serres G; Fortuno ES; Bettinger JA
    Clin Vaccine Immunol; 2013 Aug; 20(8):1108-14. PubMed ID: 23697573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.
    Skowronski DM; De Serres G; Hebert J; Stark D; Warrington R; Macnabb J; Shadmani R; Rochette L; MacDonald D; Patrick DM; Duval B
    Vaccine; 2002 Jun; 20(21-22):2713-9. PubMed ID: 12034097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solicited adverse events after influenza immunization among infants, toddlers, and their household contacts.
    Skowronski DM; Jacobsen K; Daigneault J; Remple VP; Gagnon L; Daly P; Arsenault G; Landry M; Pielak K; Duval B; Tam T; De Serres G
    Pediatrics; 2006 Jun; 117(6):1963-71. PubMed ID: 16740837
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Influenza vaccination in the 2006-2007 season].
    Alexandrescu V; Ioniţă E; Lupulescu E; Mihăilă D; Samoilă N; Apostol I; Pistol A; Canton A
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):69-74. PubMed ID: 18441961
    [No Abstract]   [Full Text] [Related]  

  • 53. Influenza vaccination coverage among persons with asthma--United States, 2005-06 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Jun; 57(24):653-7. PubMed ID: 18566564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse events associated with intranasal influenza vaccine in the United States.
    Vasu N; Ghaffari G; Craig ET; Craig TJ
    Ther Adv Respir Dis; 2008 Aug; 2(4):193-8. PubMed ID: 19124371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip.
    Delore V; Salamand C; Marsh G; Arnoux S; Pepin S; Saliou P
    Vaccine; 2006 Mar; 24(10):1586-92. PubMed ID: 16271424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.